you want to
oration from leadership
grand pharma (china) co., ltd. (former of wuhan pharmaceutical plant) was originally from a pharmaceutical plant located in the revolutionary base area—taihang mountains. during anti-japanese war and war of liberation, we have made great contributions to the whole country. president mao wrote an inscription “manufacturing drugs and keeping medical treatment with no fear of blockade are fundamental to conquer the enemies”.
70-year glorious history has characterized us as a “red pharmaceutical factory”. on the way of developing, we have never forgotten our social responsibility and try our best to pay back to the society. we still adhere with our corporate philosophy and vision so as to make contributions to chinese pharmaceutical industry.
as a member of grand pharma, we are charged with two missions: one is to inherit the spirit of dedication of the red pharmaceutical company; the other is to continuously pursue innovation and excellence.
our vision is to become a pharmaceutical company respected by chinese patients and doctors and to give back to the society. it impels us to expand our enterprise and strengthen ourselves by way of focusing on r&d and affordable quality products by which patients can be cured. moreover, doctors can be satisfied with our products as well as professional academic marketing ploys.
a group of dreamers with the consistent spirit of innovation and perseverance are good at solving complex problems. when the opportunity comes, we will lead the company to a rapid development.
brief introduction
originally from a pharmaceutical plant located in the revolutionary base area—taihang mountains, grand pharmaceutical (china) co., ltd. is a modern pharmaceutical group with a glorious history of 70 years. during anti-japanese war and war of liberation, we have made great contributions to the whole country. in 2002, we joined china grand enterprises. and in 2008, we have become the major assets of grand pharmaceutical and health holdings limited, which is listed in hong kong stock market (hk00512).
grand pharma, which includes over 10 subsidiaries, is currently a comprehensive pharmaceutical enterprise with integration of api, fdf and medical device. we are focused on ophthalmology and otorhinolaryngology products, emergency cardiovascular care products, bio-tech and customized api. in recent years, our sales revenue and profit have annually grown over 30% by means of profound strategic transformation, change of the development pattern, acceleration of independent innovation and market expansion. in 2011, we were named one of the china pharmaceutical industry top 100 enterprises. on the basis of enterprise comprehensive strength, we have been ranked in the 38th place in china chemical pharmaceutical industry in 2015.
with continuous introduction of talents, we have a professional sales team (over 1300 employees) and a specialized r&d institution with many international and high-leveled experts and consultants. well-educated and pragmatic talent reservoir prop us up in innovation and breakthrough, provide opportunities in global competition and reap the benefits of international operation.
we have been always insisting on the corporate spirit of advocating pioneering and risk-taking. with our philosophy of offering quality products, honoring code of ethics, we are working on transformation and upgrading so as to keep on enhancing the core business advantages and creating new demand. in virtue of modern management and specialized technology, we are heading towards to corporate modernization and internationalization in order to become a pharmaceutical company respected by chinese patients and doctors.
history
-
2016
acquired equity interests of xi`an beilin co., ltd.
-
2015
acquired equity interests of beijing jiuhe co., ltd.
-
2013
formed a joint venture company with huangshi feiyun co., ltd. july 2013, acquired equity interests of beijing huajin co., ltd. at the end of 2010, completed relocation of the whole company.
-
2012
formation of hubei grand bio-technology limited. november 2012, acquired hubei wellness pharmaceutical company limited.
-
2011
change of name into grand pharma (china) co., ltd., and completed brand integration of grand pharma.
-
2010
acquired hubei grand everyday bright eyes company ltd., june 2010, took over hubei grand fuchi pharmaceutical and chemical co., ltd.
-
2008
altered equity structure and indirectly listed in hk stock market.later, completed the acquisition with wuhan grand hoyo co., ltd.
-
2002
joined china grand enterprises，then renamed wuhan grand pharmaceutical co., ltd.
-
1960
the exclusive product dimercaprol saved 61 proletarian lives.
-
1953
named wuhan pharmaceutical factory.
-
1939
born in the revolutionary base area taihang mountains.
- 2016
- 2015
- 2013
- 2012
- 2011
- 2010
- 2008
- 2002
- 1960
- 1953
- 1939
corporate culture
vision
to become a pharmaceutical company respected by patients and doctors and to give back to the society.
our vision：to become a pharmaceutical company respected by patients and doctors and to give back to the society.
philosophy
offering quality products, honoring code of ethics.
our philosophy: offering quality products, honoring code of ethics.
spirit
advocating pioneering and risk-taking.<
our spirit: advocating pioneering and risk-taking.
motto
the further we move forward, the more we value the health.
our motto: the further we move forward, the more we value the health.
subsidiaries
api
-
wuhan wuyao pharmaceutical co., ltd.
wuhan wuyao pharmaceutical co., ltd. , founded in july 2002, is a subsidiary which is invested by grand pharma (china) co., ltd.
main products: analgin(metamizole sodium tablets), metronidazole buccal tablets, chloramphenicol eye drops, enoxacin tablets, pirenoxine sodium etc. over 40 kinds of api and pharmaceutical intermediates.
official website：
address：no.18, wangfen road, fuchi town, yangxin county, huangshi, hubei province, china
-
hubei grand fuchi pharmaceutical & chemicals co., ltd.
hubei grand fuchi pharmaceutical & chemicals co., ltd. was established in september 1997, and joined grand pharma (china) co., ltd in 2010.
main products: dimethyl sulfate, nitromethane, o-methylisourea derivatives, imido complex, industrial sulfuric acid, calcium superphosphate, omplex fertilizer, biological organic fertilizer.
official website：
address：no.12, wangfen road, fuchi town, yangxin county, huangshi, hubei province, china
-
fuchi pharmaceutical co., ltd.
fuchi pharmaceutical co., ltd. was established in september 2002 and joined grand pharma (china) co., ltd. in 2010.
main product: taurine.
official website：
address：no.12, wangfen road, fuchi town, yangxin county, huangshi, hubei province, china
biotech
-
wuhan grand hoyo co., ltd.
wuhan grand hoyo co., ltd. was founded in april 2000, and joined grand pharma (china) co., ltd in 2008.
main products: amino acid drugs, food additives, and refined products.
official website：
address：room 601, b block, dingye building, international business center phase iii, optics valley avenue, wuhan, hubei province, china
-
wuhan kernel bio-tech co., ltd.
wuhan kernel bio-tech co., ltd. was established in april 1999 and has been acquired by grand pharma (china) co., ltd in 2011.
it is mainly engaged in r&d, manufacturing, marketing and technical service in biological fields such as bio-pesticides, microbial-fertilizer, microbial green products and biological feed additives etc.
official website：
address：no.17, guannanyuan road, guannan science and technology industrial park, east lake high-tech development zone, wuhan, hubei province, china
-
hubei grand bio-tech co., ltd.
hubei grand bio-tech co., ltd. is a subsidiary which is invested by grand pharma (china) co., ltd in september 2012.
main product: l - cysteine.
official website：
address：no.12, wangfen road, fuchi town, yangxin county, huangshi, hubei province, china
formulations
-
grand pharma (china) co., ltd fdf branch factory
grand pharma (china) co., ltd fdf branch factory is a branch plant established in august 2013 by grand pharma (china) co., ltd.
main products: tirofiban hydrochloride sodium chloride injection (xin weining), adrenergic injection, metoprolol tartrate tablets, trimetazidine hydrochloride tablets, metronidazole buccal tablets, compound liquorice tablets.
official website：
address：no.11, huanhu middle road, dongxihu dictrict, wuhan, hubei province, china
-
hubei grand everyday bright eyes co., ltd.
hubei grand everyday bright eyes co., ltd. was established in december 2003 and has been taken over by grand pharma (china) co., ltd. in 2010.
main products: polyvinyl alcohol eye dops (ruizhu).
official website：
address：no.2, checheng north road, zhuankou economic and technological development zone, wuhan, hubei province, china
-
hubei wellness pharmaceutical co., ltd.
hubei wellness pharmaceutical co., ltd. was established in 2012 and has became a wholly-owned subsidiary of grand pharma (china) co., ltd. in december 2012.
main products: drugs: lafutidine dispersible tablets, nimesulide capsules and simvastatin capsules, erythromycin enteric-coated tablets, loratadine capsules, telmisartan hydrochlorothiazide tablets; healthcare products: super-bio l-cysteine capsules.
official website：
address： no.1, sibao road, xiantao, hubei province, china
-
grand pharmaceutical huangshi feiyun co., ltd.
grand pharmaceutical huangshi feiyun co., ltd. is a joint venture formed by grand pharma (china) co., ltd. and huangshi feiyun pharmaceutical co.,ltd. in march 2013.
main products: hydroxycamptothecin for injection, hydroxylcamptothecine injection, topotecan hydrochloride for injection, oxaliplatin for injection, glucosidorum tripterygll totorum tablets, anti-virus oral liquid etc.
official website：
address：economic and technological development zone (no.69, east of jinshan avenue ) huangshi city, hubei province, china
-
beijing huajin pharmaceutical co., ltd.
beijing huajin pharmaceutical co., ltd. was established in july 1992 and joined grand pharma (china) co., ltd. in 2013.
main products: fructose sodium diphosphate injection and fructose sodium diphosphate oral solution.
official website：
address：room 2901, c block, jin chang’an building, no.82, 4th ring east rd, chaoyang district, beijing, china
-
beijing jiuhe pharmaceutical co.,ltd.
beijing jiuhe pharmaceutical co.,ltd. was established in 1997 and joined grand pharma (china) co., ltd in 2015.
main product: eucalyptol limonene and pinene enteric soft capsules (qienuo).
official website：
address：no.8, jingbao road, doudian town, fangshan district, beijing, china
-
wuhan grand pharmaceutical group sales company ltd.
wuhan grand pharmaceutical group co., ltd. sales company ltd., which was established on november 30, 2010, is a wholly-owned subsidiary of grand pharma (china) co., ltd.
it`s a professional marketing company targeted in ophthalmology and otorhinolaryngology and cardiovascular products. the distribution channel has been covered nationally.
official website：
address：23rd floor, a block, wuhan city plaza, no.160, qiaokou road, qiaokou district, wuhan city, hubei province, china
medical device
-
tianjin jingming new technological development co., ltd.
the company was founded in october 1995 and joined grand pharma (china) co., ltd. in 2015.
main products: opthalmic hydroxy propyl methyl cellulose, medical sodium hyaluronan gel, fluorescein sodium opthalmic test paper, tears testing filter strip, tears testing phenol red cutton thread.
official website：
address：k2-8-401, haitai green industrial base, haitai fazhan sixth road, xiqing district, tianjin, china
-
cardinovum gmbh (prc jv)
cardinovum gmbh (prc jv), which was founded in october 9, 2015, is invested by grand pharma (china) co., ltd., a high-end platform for interventional medical devices.
main product: dcb-equipment.
official website：
address：23rd floor, a block, wuhan city plaza, no. 160, qiaokou road, qiaokou district, wuhan, hubei province, china
r&d
-
wuhan wuyao technology co., ltd.
wuhan wuyao technology co., ltd., which was invested by grand pharma (china) co., ltd. in june 2003, is a specialized pharmaceutical r&d institution.
official website：
address：no.2, checheng north road, zhuankou economic and technological development zone, wuhan, hubei province, china